Juvenal Lopez

Juvenal Lopez

Auto-generated profile, based on publicly available information

Juvenal Lopez

Department of Molecular Microbiology, Washington University in St. Louis School of Medicine St. Louis, Missouri, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NLNguyen-Hung Le
Nguyen-Hung Le
VPVictor Pinedo
Victor Pinedo
JLJuvenal Lopez
Juvenal Lopez
FCFelipe Cava
Felipe Cava
MFMario F. Feldman
Mario F. Feldman
Significance: Previous studies have indicated that Gram-positive bacteria are not affected by type VI secretion serum (T6SS) intoxication. However, here we show that Acinetobacter baumannii employs its T6SS to kill different Gram-positive bacteria. Furthermore, we determined that killing was dependent on Tse4, a bifunctional effector possessing lytic transglycosylase and endopeptidase activities. Tse4 represents a broad family of modularly organized T6SS peptidoglycan-degrading effectors. In addition, we show that secretion of D-lysine by A. baumannii results in a pH increase, which greatly enhances Tse4 activity. These results expand the range of T6SS-mediated interbacterial interactions that may shape the composition of bacterial communities in the context of the human microbiota and polymicrobial infections.

9 January 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
GVGisela Di Venanzio
Gisela Di Venanzio
KMKi Hwan Moon
Ki Hwan Moon
BWBrent S. Weber
Brent S. Weber
JLJuvenal Lopez
Juvenal Lopez
PLPek Man Ly
Pek Man Ly
MFMario F. Feldman
Mario F. Feldman
Acinetobacter baumannii ( Ab ) is a nosocomial pathogen with one of the highest rates of multidrug resistance (MDR). This is partially due to transmissible plasmids. Many Ab strains harbor a constitutively active type VI secretion system (T6SS) that is employed to kill nonkin bacteria. T6SS and plasmid conjugation both involve cell-to-cell contact. Paradoxically, successful conjugation requires the survival of the recipient, which is the target of the T6SS. Thus, an active T6SS in either the donor or the recipient poses a challenge to plasmid conjugation. Here, we show that large conjugative MDR plasmids heavily rely on their distinctive ability to repress the T6SS of their hosts to enable their own dissemination and the conjugation of other plasmids, contributing to the propagation of MDR among Acinetobacter isolates.

24 July 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
NLNguyen-Hung Le
Nguyen-Hung Le
KPKatharina Peters
Katharina Peters
AEAkbar Espaillat
Akbar Espaillat
JSJessica R. Sheldon
Jessica R. Sheldon
JGJoe Gray
Joe Gray
MFMario F. Feldman
Mario F. Feldman
Peptidoglycan (PG) is essential in most bacteria. Thus, it is often targeted by various assaults, including interbacterial attacks via the type VI secretion system (T6SS). Here, we report that the Gram-negative bacterium Acinetobacter baumannii strain ATCC 17978 produces, secretes, and incorporates the noncanonical d-amino acid d-lysine into its PG during stationary phase. We show that PG editing increases the competitiveness of A. baumannii during bacterial warfare by providing immunity against peptidoglycan-targeting T6SS effectors from various bacterial competitors. In contrast, we found that d-Lys production is detrimental to pathogenesis due, at least in part, to the activity of the human enzyme d-amino acid oxidase (DAO), which degrades d-Lys producing H2O2 toxic to bacteria. Phylogenetic analyses indicate that the last common ancestor of A. baumannii had the ability to produce d-Lys. However, this trait was independently lost multiple times, likely reflecting the evolution of A. baumannii as a human pathogen.

25 February 2020 in mBio
Verified
Journal Article
Open access
PDF file
JLJuvenal Lopez
Juvenal Lopez
PLPek Man Ly
Pek Man Ly
MFMario F. Feldman
Mario F. Feldman
The type VI secretion system (T6SS) is a critical weapon in bacterial warfare between Gram-negative bacteria. Although invaluable for niche establishment, this machine represents an energetic burden to its host bacterium. Acinetobacter baumannii is an opportunistic pathogen that poses a serious threat to public health due to its high rates of multidrug resistance. In some A. baumannii strains, the T6SS is transcriptionally downregulated by large multidrug resistance plasmids. Other strains, such as the clinical isolate AbCAN2, express T6SS-related genes but lack T6SS activity under laboratory conditions, despite not harboring these plasmids. This suggests that alternative mechanisms exist to repress the T6SS. Here, we used a transposon mutagenesis approach in AbCAN2 to identify novel T6SS repressors. Our screen revealed that the T6SS of this strain is inhibited by a homolog of VgrG, an essential structural component of all T6SSs reported to date. We named this protein inhibitory VgrG (VgrGi). Biochemical and in silico analyses demonstrated that the unprecedented inhibitory capability of VgrGi is due to a single amino acid mutation in a widely conserved C-terminal domain of unknown function, DUF2345. We also show that unlike in other bacteria, the C terminus of VgrG is essential for functional T6SS assembly in A. baumannii. Our study provides insight into the architectural requirements underlying functional assembly of the T6SS of A. baumannii. We propose that T6SS-inactivating point mutations are beneficial to the host bacterium, since they eliminate the energy cost associated with maintaining a functional T6SS, which appears to be unnecessary for A. baumannii virulence. IMPORTANCE Despite the clinical relevance of A. baumannii, little is known about its fundamental biology. Here, we show that a single amino acid mutation in VgrG, a critical T6SS structural protein, abrogates T6SS function. Given that this mutation was found in a clinical isolate, we propose that the T6SS of A. baumannii is probably not involved in virulence; this idea is supported by multiple genomic analyses showing that the majority of clinical A. baumannii strains lack proteins essential to the T6SS. We also show that, unlike in other species, the C terminus of VgrG is a unique architectural requirement for functional T6SS assembly in A. baumannii, suggesting that over evolutionary time, bacteria have developed changes to their T6SS architecture, leading to specialized systems.

1 December 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
RKRachel L. Kinsella
Rachel L. Kinsella
JLJuvenal Lopez
Juvenal Lopez
LPLauren D. Palmer
Lauren D. Palmer
NSNichole D. Salinas
Nichole D. Salinas
ESEric P. Skaar
Eric P. Skaar
MFMario F. Feldman
Mario F. Feldman
Acinetobacter baumannii, Acinetobacter nosocomialis, and Acinetobacter pittii are a frequent cause of multidrug-resistant, healthcare-associated infections. Our previous work demonstrated that A. nosocomialis M2 possesses a functional type II secretion system (T2SS) that is required for full virulence. Further, we identified the metallo-endopeptidase CpaA, which has been shown previously to cleave human Factor V and deregulate blood coagulation, as the most abundant type II secreted effector protein. We also demonstrated that its secretion is dependent on CpaB, a membrane-bound chaperone. In this study, we show that CpaA expression and secretion are conserved across several medically relevant Acinetobacter species. Additionally, we demonstrate that deletion of cpaA results in attenuation of A. nosocomialis M2 virulence in moth and mouse models. The virulence defects resulting from the deletion of cpaA were comparable with those observed upon abrogation of T2SS activity. The virulence defects resulting from the deletion of cpaA are comparable with those observed upon abrogation of T2SS activity. We also show that CpaA and CpaB strongly interact, forming a complex in a 1:1 ratio. Interestingly, deletion of the N-terminal transmembrane domain of CpaB results in robust secretion of CpaA and CpaB, indicating that the transmembrane domain is dispensable for CpaA secretion and likely functions to retain CpaB inside the cell. Limited proteolysis of spheroplasts revealed that the C-terminal domain of CpaB is exposed to the periplasm, suggesting that this is the site where CpaA and CpaB interact in vivo. Last, we show that CpaB does not abolish the proteolytic activity of CpaA against human Factor V. We conclude that CpaA is, to the best of our knowledge, the first characterized, bona fide virulence factor secreted by Acinetobacter species.

12 October 2021 in Journal of Bacteriology
Verified
Journal Article
Open access
JLJuvenal Lopez
Juvenal Lopez
NLNguyen-Hung Le
Nguyen-Hung Le
KMKi Hwan Moon
Ki Hwan Moon
Dor SalomonDor Salomon
Dor Salomon
EBEran Bosis
Eran Bosis
MFMario F Feldman
Mario F Feldman
Despite the wealth of knowledge on the diversity of biochemical activities carried out by T6SS effectors, comparably little is known about the various strategies that bacteria employ to prevent susceptibility to T6SS-dependent bacterial killing. Our work establishes a novel family of T6SS immunity proteins with a characteristic FGE domain.